Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Eli Lilly is pouring another $4.5 billion into expanding manufacturing and development as the drugmaker rakes in billions from new product sales. The
Eli Lilly to build $4.5 billion Indiana facility for advanced drug manufacturing
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027.
Lilly to invest $4.5 billion on new facility to scale-up pipeline drug production
U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center in Indiana that will focus on developing new ways to manufacture its drugs and increasing production of experimental medicines used in clinical studies.
Eli Lilly to Build $4.5B Research, Manufacturing Plant in Indiana
Eli Lilly will spend $4.5 billion to build a new plant in Indiana that combines research and manufacturing in a single location. Lilly on Wednesday said the plant, dubbed the Lilly Medicine Foundry, is the first of its kind and will give the Indianapolis drugmaker the ability to research new ways of producing medicines while also scaling up manufacturing of drug for clinical trials for its growing pipeline.
Lilly Shells Out $4.5 Billion for New Drug Development Plant
Eli Lilly & Co. is pouring $4.5 billion into a new manufacturing plant in Indiana to make drugs for future clinical trials, part of a broader push to shore up the company’s supply chain.
Eli Lilly To Create Indiana Medicine Foundry For Advanced Manufacturing And Drug Development
Eli Lilly (LLY) announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and
Eli Lilly is building a $4.5 billion factory to speed up drug production
Pharmaceutical giant Eli Lilly (LLY) is putting $4.5 billion toward building a new site to develop and manufacture drugs.
Mexico’s first female president promises ‘no return to drug war’
Mexico’s first female president promised that there will be no return to the “irresponsible” drug war between the government ...
Cannabis may soon be rescheduled as a less dangerous drug. 5 things you need to know
Cannabis, or marijuana, may be reclassified from a Schedule I to a Schedule III drug, loosening some federal restrictions.
Myanmar civil war fuels surge in cross-border drug trade, Thailand official says
Thailand has seen a surge in illegal drugs trafficked from neighbouring Myanmar and a sharp increase in methamphetamines and ...
A Houston Drug Cop's Murder Conviction Highlights the Potentially Deadly Consequences of 'Testilying'
Nearly six years ago, Houston drug cops killed a middle-aged couple, Dennis Tuttle and Rhogena Nicholas, after breaking into ...
STAT2h
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
BRPD: Pair arrested in drug bust; cocaine, cash seized
The Baton Rouge Police Department confirmed its Special Investigations Division executed a search warrant at an address on ...
Why the FTC Suit Against Drug Benefit Managers Is an Unusual Step
Bryan Cave attorneys assess an FTC complaint against pharmacy benefit managers, noting that collateral bias and ...
ABC Action News20m
2 men arrested after robbing undercover detective during drug deal, shooting deputy: MCSO says
The Manatee County Sheriff's Office said two suspects were arrested after allegedly robbing an undercover detective during a drug deal and shooting at another deputy.
Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022.
Toilets dirty with drug user 'blood and needles'
Charges could be levied on town centre toilets to deter drug users leaving them dirty with "blood" and discarded needles.